DOCSLIB.ORG

Acquired Hematopoietic Stem Cell Defects Determine B-Cell Repertoire Changes Associated with Aging

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acquired Hematopoietic Stem Cell Defects Determine B-Cell Repertoire Changes Associated with Aging Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging Lisa M. Guerrettaz*, Sara A. Johnson*, and John C. Cambier*† Department of Immunology, University of Colorado, Denver School of Medicine and National Jewish Health, Denver, CO 80206 Communicated by Philippa Marrack, National Jewish Medical and Research Center, Denver, CO, June 9, 2008 (received for review February 28, 2008) Aging is associated with an inability to mount protective antibody decreased ability of LT-HSCs from aged animals to replenish the responses to vaccines and infectious agents. This decline is asso- follicular compartment. Studies described in this report test this ciated with acquisition of defects in multiple cellular compart- hypothesis. ments, including B cells. While peripheral B-cell numbers do not A major obstacle to studying the effects of aging on the B-cell decline with aging, the composition of the compartment appears compartment is the difficulty of resolving B-cell repertoire to change, with loss of naı¨ve follicular B cells, accumulation of changes in wild type (WT) mice where B cells exhibit diverse Ig antigen-experienced cells, and alteration of the antibody reper- specificity. Therefore, to address the relationship between the toire. The underlying cause of this change is unknown. We tested age-associated decline in B lymphopoiesis and the peripheral the hypothesis that aging-associated repertoire changes can be B-cell repertoire, we used the 3-83 ␮␦ Ig transgenic (Tg) mouse attributed directly to decreased B lymphopoiesis. Using an Ig model. In young 3-83 ␮␦ mice, ϳ93% of B cells express transgene transgenic model to report changes in the B-cell repertoire, we encoded Igs (tgIg) specific for the MHC class I antigen H-2Kk/b, show that the reduced B-cell generative capacity of ‘‘aged’’ long- an exotic antigen in the H-2Kd mice (B10.D2) used in this study term reconstituting hematopoietic stem cells (LT-HSCs) alters the (15). The remaining B cells in these mice express B-cell receptors representation of antigen specificities in the peripheral B-cell encoded by endogenous Ig (enIg) genes. As reported previously, repertoire. Further, we show that reconstitution using suboptimal immature B cells in the bone marrow of aged 3-83 ␮␦ mice numbers of fully functional LT-HSCs results in the generation of a maintain this ratio of 93% tgIg:7% enIg (6). Importantly how- similarly altered B-cell repertoire. This may be an important factor ever, in these same aged mice the frequency of peripheral B cells to consider when deciding the number of bone marrow cells to (B cells in blood, spleen, and lymph nodes) expressing tgIg transplant in the clinical setting. In conclusion, when B lympho- decreases, and the compartment becomes dominated by cells poiesis is limited peripheral B-cell homeostasis is altered. This is expressing enIg that appear, on the basis of surface phenotype, ϩ reflected in reduced diversity of the B-cell repertoire, which likely to be antigen experienced (memory, marginal zone, and CD5 reduces the protective quality of the immune response. B1-like). By 18 months of age, ϳ90% of 3-83 ␮␦ mice express a B-cell compartment skewed in favor of enIg. In ϳ75% of these Ͼ ollicular (FO) lymphocytes are the largest B-cell subpopu- mice, 60% of B cells express enIg (6). Furthermore, this enIg Flation in peripheral lymphoid organs and display the maxi- population is highly enriched in cells specific for auto- and mum breadth of germline-encoded antibody specificity for for- environmental antigens, a hallmark of aging. Finally in aged 3-83 ␮␦ eign antigens. Because of the breadth of this repertoire, these mice, naive FO B cells are reduced in number and uniformly naı¨ve FO cells are uniquely suited to give rise to protective express transgene-encoded receptors. Thus, in this model system primary immune responses and to be selected for high-affinity a shift in the peripheral B-cell repertoire away from tgIg and antibody production. toward enIg expression is an easily measured indicator of Aging is associated with decreased efficacy of vaccination in immunologic aging. both humans and mice, increased susceptibility to infection, and Using this model, we show that although LT-HSCs increase in increased rate of cancer (1–4). In mice, where it can be exam- number as mice age, these LT-HSCs lose functionality, resulting ined, aging is associated with a reduction in FO B cells, but not in decreased ability to generate B cells. This decreased output of total B-cell numbers (5, 6). This reduction in FO B-cell numbers naive B cells from the BM determines the aged peripheral is further associated with a reduction in immunoglobulin (Ig) repertoire. Furthermore, artificial limitation of HSC function in diversity within the B-cell pool and an increase in the frequency young animals mimics aging, generating a B-cell repertoire of antigen-experienced cells, including marginal zone, B1, and skewed toward nonfollicular cell types. memory cells. In young animals the sizes of these compartments Results and Discussion is independently regulated (7). Thus, it seems plausible that the humoral immune defects seen in aging may be the consequence Aging-Associated B-Cell Repertoire Changes Are Caused by Stem-Cell of reduced frequency of FO B cells bearing high-affinity recep- Defects. To assess the stem-cell contribution to aging-associated tors for offensive pathogens. changes in the peripheral B-cell repertoire, we analyzed the ability of bulk HSC populations from prescreened immunologically aged, FO B cells are short-lived (estimates ranging from 40 to 120 d) Ͼ ␮␦ and nonself-renewing and therefore must be constantly replen- i.e., mice in which 60% of B cells express enIg, 3-83 mice to ished by new B cells produced in hematopoietic organs, e.g., recapitulate, in young lethally irradiated WT recipients, the reper- adult bone marrow (BM) (8, 9). For reasons that are unclear, transplanted bone marrow stem cells from older adult human Author contributions: L.M.G., S.A.J., and J.C.C. designed research; L.M.G. and S.A.J. per- donors often do not give rise to B cells in recipients (10). formed research; L.M.G., S.A.J., and J.C.C. analyzed data; and L.M.G., S.A.J., and J.C.C. wrote Similarly, LT-HSCs from aged mice, while more numerous than the paper. in young animals, are selectively impaired in the ability to The authors declare no conflict of interest. reconstitute the B-cell compartment of irradiated recipients (11, Freely available online through the PNAS open access option. 12). Finally, autoreconstitution of B cells following lymphoab- *These authors contributed equally to this work. lation is impaired in aged mice (13, 14). On the basis of these †To whom correspondence should be addressed at: Department of Immunology, K803A, findings we hypothesize that the poor quality of the primary National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206. antibody response seen in the aged results from a decline in naive E-mail: [email protected]. follicular B-cell numbers, which is in turn the result of the © 2008 by The National Academy of Sciences of the USA 11898–11902 ͉ PNAS ͉ August 19, 2008 ͉ vol. 105 ͉ no. 33 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0805498105 Downloaded by guest on September 26, 2021 B10.D2 Recipient A Young Aged Young Aged 3.45 96.1 2.94 96.5 2.11 6.67 Young cKit 3-83µδ 0.37 0.037 0.38 0.15 Sca-1 Donor BM 89.3 10.4 90.7 9.17 B Young B10.D2 Recipients 89.6 0.29 27.3 40 Aged Aged µδ 0.27 0.012 0.097 0 3-83 10.1 0 31.6 1.1 B220 LT-HSC 5.92 92.2 22.4 38 Idiotype Donor Fig. 1. Aging-associated decline in B lymphopoiesis is B-cell/stem cell auton- Young omous. Young or aged WT (B10.D2) mice were lethally irradiated, and lym- 1.65 0.21 38.8 0.73 phocyte-depleted bone marrow cells from young or prescreened immunolog- ically aged 3-83␮␦ animals were transferred by i.v. injection. Donor BM was β pooled from multiple animals before depletion, and BM equivalents were IgM TCR transferred at a ratio of one donor equivalent to four recipients. Reconstitu- Idiotype CD4 tion of the peripheral B-cell compartment was assessed 6 weeks posttransfer. Splenocytes were gated on live, CD19ϩ B cells, and 3-83␮␦ idiotype and total p<.0001* C 100 IgM expression was evaluated. Data are representative of analyses of a Young Lindep BM minimum of three individual animals in each category. Young 5FU BM 80 Young LT-HSC dep B cells 60 Aged Lin BM toire changes seen in the HSC donors. Furthermore, to assess the + Aged 5FU BM role played by the BM microenvironment in the development of the Aged LT-HSC aged B-cell repertoire, the converse experiment, in which bulk 40 HSCs from young 3-83 ␮␦ mice were transferred into aged lethally 20 irradiated recipients, was also performed. B-cell reconstitution was % Idiotype assessed 6 weeks posttransfer by flow cytometric analysis of the 0 splenic B-cell compartment. As shown in Fig. 1, lymphocyte- Young Aged depleted BM from young 3-83 ␮␦ mice reconstituted a young-like (predominantly tgIg, idiotype positive) repertoire in both young and Donors old recipients (top panels), whereas lymphocyte-depleted BM from ␮␦ Fig. 2. LT-HSCs from aged animals exhibit reduced B-cell generative capacity aged 3-83 mice reconstituted an aged-like (predominantly enIg, associated with repertoire alteration. Untreated whole BM was harvested idiotype negative) repertoire in both young and old recipients from four young or four aged mice, RBCs were lysed, and LT-HSCs purified as (bottom panels).
Load more

Recommended publications
  • Toll-Like Receptor 9 Signaling Acts on Multiple Elements of the Germinal Center to Enhance Antibody Responses
    Toll-like receptor 9 signaling acts on multiple elements PNAS PLUS of the germinal center to enhance antibody responses Derek C. Rookhuizena,1 and Anthony L. DeFrancob,2 aDepartment of Molecular and Cell Biology, Life Sciences Addition, University of California, Berkeley, CA 94720; and bDepartment of Microbiology and Immunology, University of California, San Francisco, CA 94143 Edited by David Tarlinton, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, and accepted by the Editorial Board June 24, 2014 (received for review December 23, 2013) Recent studies have demonstrated important roles of nucleic acid- where they provide survival and selection cues to antigen-pre- sensing Toll-like receptors (TLRs) in promoting protective antibody senting B cells through T-cell receptor (TCR) recognition of responses against several viruses. To dissect how recognition of antigenic peptide–MHC II complexes, costimulatory ligand– nucleic acids by TLRs enhances germinal center (GC) responses, receptor pairs, and cytokine production (8, 15, 16). Recently, + + mice selectively deleted for myeloid differentiation primary- it has become clear that some follicular CXCR5 CD4 T cells are + response protein 88 (MyD88) in B cells or dendritic cells (DCs) were thymically derived FoxP3 regulatory T cells, referred to as fol- immunized with a haptenated protein antigen bound to a TLR9 licular regulatory T (TFR) cells (17–22). Although their function ligand. TLR9 signaling in DCs led to greater numbers of follicular is poorly understood at this point, TFR cells appear to limit the helper T (TFH) cells and GC B cells, and accelerated production of size of the GC response (17–20).
    [Show full text]
  • B Cell Immunity in Solid Organ Transplantation
    REVIEW published: 10 January 2017 doi: 10.3389/fimmu.2016.00686 B Cell Immunity in Solid Organ Transplantation Gonca E. Karahan, Frans H. J. Claas and Sebastiaan Heidt* Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands The contribution of B cells to alloimmune responses is gradually being understood in more detail. We now know that B cells can perpetuate alloimmune responses in multiple ways: (i) differentiation into antibody-producing plasma cells; (ii) sustaining long-term humoral immune memory; (iii) serving as antigen-presenting cells; (iv) organizing the formation of tertiary lymphoid organs; and (v) secreting pro- as well as anti-inflammatory cytokines. The cross-talk between B cells and T cells in the course of immune responses forms the basis of these diverse functions. In the setting of organ transplantation, focus has gradually shifted from T cells to B cells, with an increased notion that B cells are more than mere precursors of antibody-producing plasma cells. In this review, we discuss the various roles of B cells in the generation of alloimmune responses beyond antibody production, as well as possibilities to specifically interfere with B cell activation. Keywords: HLA, donor-specific antibodies, antigen presentation, cognate T–B interactions, memory B cells, rejection Edited by: Narinder K. Mehra, INTRODUCTION All India Institute of Medical Sciences, India In the setting of organ transplantation, B cells are primarily known for their ability to differentiate Reviewed by: into long-lived plasma cells producing high affinity, class-switched alloantibodies. The detrimental Anat R. Tambur, role of pre-existing donor-reactive antibodies at time of transplantation was already described in Northwestern University, USA the 60s of the previous century in the form of hyperacute rejection (1).
    [Show full text]
  • Extrafollicular Proliferation of B Cells in the Absence of Follicular Hyperplasia
    Histopathology 2005, 47, 90–100. DOI: 10.1111/j.1365-2559.2005.02173.x Extrafollicular proliferation of B cells in the absence of follicular hyperplasia: a distinct reaction pattern in lymph nodes correlated with primary or recall type responses A Brighenti, M Andrulis,1 E Geissinger,1 S Roth,1 HKMu¨ller-Hermelink1 &TRu¨diger1 Istituto di Anatomia Patologica, Universita` degli Studi di Verona, Verona, Italy, and 1Institute of Pathology, University of Wu¨rzburg, Wu¨rzburg, Germany Date of submission 30 April 2004 Accepted for publication 10 March 2005 Brighenti A, Andrulis M, Geissinger E, Roth S, Mu¨ller-Hermelink H K & Ru¨diger T (2005) Histopathology 47, 90–100 Extrafollicular proliferation of B cells in the absence of follicular hyperplasia: a distinct reaction pattern in lymph nodes correlated to primary or recall type responses Aims: Extrafollicular activation of B cells is rarely cases proliferating cells were mainly IgG+CD27+, i.e. observed in human lymph nodes. The aim of this study derived from class-switched postgerminal centre mem- was to extensively analyse the expression of surface ory B cells. Some of these cells expressed CD30. In the molecules and transcription factors in four such cases, other two cases, immunoglobulin-forming cells were comparing them with follicular B cells and medullary non-class-switched IgM+CD27– B cells, representing a cord plasma cells. primary expansion of naive B cells. Methods and results: Various combinations of B-cell- Conclusions: Extrafollicular B-cell activation is the related surface markers and transcription factors were morphological correlate of rapid B-cell responses that studied by triple immunofluorescence.
    [Show full text]
  • Signals for B Cell Activation in Antibody Response
    Signals for B cell activation in Antibody response YANG ZHANG A thesis is submitted to the University of Birmingham for the degree of Doctor of Philosophy School of immunity & Infection College of Medicine and Dental Science University of Birmingham June 2010 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Abstract Germinal centres (GCs) are the sites where V-gene hypermutation and B cell selection are taking place. Testing specificity and affinity of GC B cell receptor by interaction with antigen on follicular dendritic cells (FDCs) may be an important selection process to select high affinity B cell clone. As antigen on FDC is present in the form of antigen-antibody immune complex, GC B cells are expected to have to compete with antibody to get access antigen. Initially this antibody will be of low affinity. However, during the course of an immune response, this affinity may increase. We have tested this competitive selection model by following the replacement of antibodies in the GC over the course of an immune response. The speed of this replacement is dependent on affinity.
    [Show full text]
  • REVIEW Anti-CD20-Based Therapy of B Cell Lymphoma: State of The
    Leukemia (2002) 16, 2004–2015 2002 Nature Publishing Group All rights reserved 0887-6924/02 $25.00 www.nature.com/leu REVIEW Anti-CD20-based therapy of B cell lymphoma: state of the art C Kosmas1, K Stamatopoulos2, N Stavroyianni2, N Tsavaris3 and T Papadaki4 1Department of Medicine, 2nd Division of Medical Oncology, ‘Metaxa’ Cancer Hospital, Piraeus, Greece; 2Department of Hematology, G Papanicolaou General Hospital, Thessaloniki, Greece; 3Oncology Unit, Department of Pathophysiology, Athens University School of Medicine, Laikon General Hospital, Athens, Greece; and 4Hemopathology Department, Evangelismos Hospital, Athens, Greece Over the last 5 years, studies applying the chimeric anti-CD20 ficulties in identifying a completely tumor-specific target; (2) MAb have renewed enthusiasm and triggered world-wide appli- the impracticality of constructing a unique antibody for each cation of anti-CD20 MAb-based therapies in B cell non-Hodg- kin’s lymphoma (NHL). Native chimeric anti-CD20 and isotope- patient; (3) the development of an immune response to murine 6 labeled murine anti-CD20 MAbs are currently employed with immunoglobulins (human anti-mouse antibodies, HAMA). By encouraging results as monotherapy or in combination with the end of the 1980s enthusiasm for therapeutic MAbs was conventional chemotherapy and in consolidation of remission waning; murine native (unconjugated), radioactively labeled after treatments with curative intent (ie after/ in combination or toxin-conjugated MAbs failed to yield significant clinical with high-dose chemotherapy and hematopoietic stem cell responses; moreover, they were not uncommonly associated rescue). On the available experience, anti-CD20 MAb-based therapeutic strategies will be increasingly integrated in the with toxicities, predominantly in the form of serum sickness treatment of B cell NHL and related malignancies.
    [Show full text]
  • An Overview of B Cells – from Discovery to Therapy Mini Review
    An Overview of B Cells – from Discovery to Therapy Mini Review Immunology In the past two decades, significant advances have been made in B cell biology. These critical immune cells remain an active area of research particularly because disruption of B cell development or function results in a number of autoimmune diseases and malignancies. In addition to producing antibodies, B cells are professional antigen presenting cells that can present antigens to T cells to generate effective immune responses. B cells are however, a heterogeneous population of cells at different stages of maturation along the lineage, each with unique functional properties. This mini-review provides a brief history of the discovery of B cells, as well as describes the characteristics of each B cell lineage and the processes of B cell development, maturation and activation. Finally, we highlight the application of B cell biology in the development of novel therapeutics for the treatment of B cell mediated diseases. Contents 1. A brief history of the discovery of B cells 2. B cell development and maturation 3. B cell activation and the humoral immune response 4. B cells as therapeutic targets 1. A brief history of the discovery of B cells B cells are an integral part of the adaptive immune response. They represent a distinct lineage, with separate and unique functions from T cells. In addition to producing antibodies, they perform critical immune functions such as generating immunological memory, antigen presentation and regulatory cytokine production. Our current understanding of B cell biology was initiated in 1965 with a landmark study by Max Cooper and Robert Good.
    [Show full text]
  • Characterization of Intratumoral Follicular Helper T Cells in Follicular Lymphoma: Role in the Survival of Malignant B Cells
    Leukemia (2012) 26, 1053 --1063 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu ORIGINAL ARTICLE Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells P Ame´ -Thomas1,2,3,4,9, J Le Priol1,2,3,9, H Yssel5, G Caron1,2,3,4, C Pangault1,2,3,4, R Jean1,2,3,4, N Martin6,7, T Marafioti8, P Gaulard6,7, T Lamy1,2,3,4, T Fest1,2,3,4, G Semana1,2,3 and K Tarte1,2,3,4 Accumulating evidences indicate that the cellular and molecular microenvironment of follicular lymphoma (FL) has a key role in both lymphomagenesis and patient outcome. Malignant FL B cells are found admixed to specific stromal and immune cell pos subsets, in particular CD4 T cells displaying phenotypic features of follicular helper T cells (TFH). The goal of our study was to functionally characterize intratumoral CD4pos T cells. We showed that CXCR5hiICOShiCD4pos T cells sorted from FL biopsies comprise at least two separate cell populations with distinct genetic and functional features: (i) CD25pos follicular regulatory neg T cells (TFR), and (ii) CD25 TFH displaying a FL-B cell supportive activity without regulatory functions. Furthermore, despite their strong similarities with tonsil-derived TFH, purified FL-derived TFH displayed a specific gene expression profile including an overexpression of several genes potentially involved directly or indirectly in lymphomagenesis, in particular TNF, LTA, IL4 or CD40LG. Interestingly, we further demonstrated that these two last signals efficiently rescued malignant B cells from spontaneous and rituximab-induced apoptosis.
    [Show full text]
  • The Bone Marrow Perisinusoidal Niche for Recirculating B Cells and the Positive Selection of Bone Marrow-Derived B Lymphocytes
    Immunology and Cell Biology (2009) 87, 16–19 & 2009 Australasian Society for Immunology Inc. All rights reserved 0818-9641/09 $32.00 www.nature.com/icb REVIEW The bone marrow perisinusoidal niche for recirculating B cells and the positive selection of bone marrow-derived B lymphocytes Shiv Pillai and Annaiah Cariappa A unique ‘second’ niche for follicular B cells has been described in the extravascular compartment of the bone marrow surrounding vascular sinusoids. The occupancy of this niche by B cells presumably evolved to facilitate humoral immune responses to blood-borne pathogens. B cells appear to be sustained in this niche by bone marrow dendritic cells and are lost from this compartment in certain mutant mice. We discuss here what is known regarding the mechanisms of entry and egress of B cells from the perisinusoidal niche and also consider the function of the bone marrow as a secondary lymphoid organ. Although immature B cells can mature into follicular B cells in this niche as well as in the spleen, the lineage commitment event that accompanies positive selection of B cells occurs only in the spleen. Immunology and Cell Biology (2009) 87, 16–19; doi:10.1038/icb.2008.89; published online 25 November 2008 Keywords: perisinusoidal B cells; follicular B cells; positive selection; lymphocyte development; bone marrow; secondary lymphoid organ B cells in adult vertebrates develop initially in the bone marrow. About marrow.6 Although follicular B cells are supported in the conventional two-thirds of surface immunoglobulin M (IgM)-expressing immature follicular niche by follicular dendritic cells secreting the tumor B cells that have survived tolerance-related checkpoints exit the bone necrosis factor family member B cell activating factor of the TNF marrow and migrate to the spleen, whereas the remaining immature B family (BAFF), the survival of these very same B cells when they reside cells continue to mature in the bone marrow itself 1,2 (Figure 1).
    [Show full text]
  • Molecular Genetics of B- and T Lymphocyte Development
    UMEÅ UNIVERSITY MEDICAL DISSERTATIONS New series no.1030, ISSN 0346-6612, ISBN 91-7264-089-8 Molecular Genetics of B- and T Lymphocyte Development Ingela Wikström Department of Medical Biosciences Unit of Medical and Clinical Genetics Umeå University Sweden 2006 Department of Medical Biosciences Unit of Medical and Clinical Genetics Umeå University SE-901 85 Umeå, Sweden Copyright © 2006 by Ingela Wikström ISSN 0346-6612 ISBN 91-7264-089-8 Printed by Solfjädern Offset AB in Umeå, Sweden, 2006 2 Table of contents Abstract………….……………………………………………………………......................5 Abbreviations………………………………...……………………………………………...6 Articles……………………………………………………………………...……….………7 Introduction…………………………………………………………………………………8 1.1 The immune system…………………………………………...………………………...8 The non-specific immune system………………………………………………………...8 The specific immune system……………………………………………………………..8 1.2 Function of lymphocytes………………………………………………………………..9 B lymphocytes…………………………………………………………………………....9 T lymphocytes…………………………………………………………………………..13 1.3 Lymphocyte development……………………………………………………………..17 B cell development………………………………………………………………….…..17 T cell development……………………………………………………………………...21 2.1 Transcription factors controlling lymphocyte development….…………………….25 2.2 Basic helix-loop-helix transcription factors………………………………………….27 Structure, function and subclasses of bHLH proteins…………………………………..28 Regulation of E-protein activity………………………………………………………...30 E-proteins in B cell development……………………………………………………….31 E-proteins in T cell development………………………………………………………..35
    [Show full text]
  • Murine Norovirus Inhibits B Cell Development in Bone Marrow, but Does Not Impair Antibody
    Murine norovirus inhibits B cell development in bone marrow, but does not impair antibody production in Stat1-/- mice Daniel Eldridge A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science University of Washington 2021 Reading Committee: Charlie C. Hsu Brian Iritani Jisun Paik Program Authorized to Offer Degree: Comparative Medicine © Copyright 2021 Daniel Eldridge University of Washington Abstract Murine norovirus inhibits B cell development in bone marrow, but does not impair antibody production in Stat1-/- mice Daniel Eldridge Chair of the Supervisory Committee: Charlie C. Hsu Department of Comparative Medicine Murine norovirus (MNV) is used as a model system to study human noroviruses, can infect macrophages/monocytes, neutrophils, dendritic, intestinal epithelial, T and B cells, and is highly prevalent in laboratory mice. We previously showed that MNV infection significantly reduces bone marrow B cell populations in a Stat1-dependent manner. We demonstrate here that while MNV-infected Stat1-/- mice have significant bone marrow B cell losses, expansion of splenic B cells capable of mounting an antibody response to novel antigens remains intact. We also investigated increased granulopoiesis as a mechanism of B cell loss, and we show that administration of anti-G-CSF antibody inhibits the pronounced bone marrow granulopoiesis induced by MNV infection of Stat1-/- mice, but this inhibition does not rescue bone marrow B cell losses. Therefore, these results show that MNV-infected Stat1-/- mice can still exhibit a robust humoral immune response in spite of decreased bone marrow B cells, and suggests that further investigation will be needed to identify other indirect factors or mechanisms that are responsible for the bone marrow B cell losses seen after MNV infection.
    [Show full text]
  • Pools the Marginal Zone and Follicular B Cell IFN Regulatory
    IFN Regulatory Factor 8 Restricts the Size of the Marginal Zone and Follicular B Cell Pools This information is current as Jianxun Feng, Hongsheng Wang, Dong-Mi Shin, Marek of September 24, 2021. Masiuk, Chen-Feng Qi and Herbert C. Morse III J Immunol 2011; 186:1458-1466; Prepublished online 22 December 2010; doi: 10.4049/jimmunol.1001950 http://www.jimmunol.org/content/186/3/1458 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2010/12/22/jimmunol.100195 Material 0.DC1 http://www.jimmunol.org/ References This article cites 48 articles, 31 of which you can access for free at: http://www.jimmunol.org/content/186/3/1458.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 24, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology IFN Regulatory Factor 8 Restricts the Size of the Marginal Zone and Follicular B Cell Pools Jianxun Feng,*,1 Hongsheng Wang,*,1 Dong-Mi Shin,* Marek Masiuk,*,† Chen-Feng Qi,* and Herbert C.
    [Show full text]
  • Characterization of B Cell Development and Activation in the Absence of Akt Or Presenilin
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Spring 2010 Characterization of B Cell Development and Activation in the Absence of Akt or Presenilin Marco Calamito University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Immunology and Infectious Disease Commons Recommended Citation Calamito, Marco, "Characterization of B Cell Development and Activation in the Absence of Akt or Presenilin" (2010). Publicly Accessible Penn Dissertations. 163. https://repository.upenn.edu/edissertations/163 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/163 For more information, please contact [email protected]. Characterization of B Cell Development and Activation in the Absence of Akt or Presenilin Abstract The biochemical pathways critical to B cell development remain poorly defined. Here I characterize a critical role for two separate families of proteins, Akt and Presenilin in the development and activation of B cells. The absence of Akt1 and Akt2 leads to a block in marginal zone (MZ) and B1B cell development, as well as decreased cellularity of splenic follicular B cells. In addition, I find the combined loss of Akt1 and Akt2 causes altered B cell receptor repertoire and poor competitive ability when matched against wild-type B cells. Similar to deficiencies in the Akt pathway the combined loss of Presenilin1 and Presenilin2 results in defective MZ, B1B cell development, and altered BCR repertoire selection. Furthermore, I find that these defects are independent of the Notch pathway and that Presenilins are required for optimal responses to cross-linking of the BCR.
    [Show full text]